The COVID-19 pandemic is the greatest public health crisis the U.S. has ever faced. The Duke-Margolis Center for Health Policy has marshalled its outstanding network of experts to respond to the crisis in real time, guiding Federal and state leaders through this extraordinarily difficult period. Interdisciplinary faculty and researchers from Duke University, Duke Health System and other leading health organizations are collaborating on vital, evidence-based strategies needed now to address the pandemic.

Duke-Margolis has put forward key policy steps leaders must take to respond comprehensively to the COVID-19 pandemic, to reopen the nation successfully, and create a more secure health care system. At the same time, the Center continues its vital mission to educate tomorrow’s health policy leaders, develop and analyze new data, provide timely thought leadership, and engage the greater public through outreach and education.

Duke University, COVID Collaborative, Duke Global Health Institute, Duke Global Health Institute, Duke-Margolis Center for Health Policy

Duke-Margolis Center for Health Policy; MITRE; CURE Drug Repurposing Collaboratory (C-Path + NCATS+ FDA); Emory-Morningside Center for Innovative and Affordable Medicine; Intermountain Healthcare; Mayo Clinic; University of California, Irvine; Duke University Health System; and Broad Institute of MIT and Harvard.

Duke-Margolis aims to transform health care, energize biomedical innovation, move us forward toward health equity, and engage and educate tomorrow’s health care leaders. Through Health Policy Talks, Duke-Margolis will provide a premiere opportunity for distinguished health policy leaders to share their vision and thought leadership to a broad, informed, and consequential health policy audience—as well as educate and inspire future health care leaders.